COSCIENS Biopharma Inc. Increase Decrease In Cash And Cash Equivalents
COSCIENS Biopharma Inc. (CSCIF) reported Increase Decrease In Cash And Cash Equivalents of -$9.09 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2026-03-25
- COSCIENS Biopharma Inc. increase decrease in cash and cash equivalents for the quarter ending 2025-12-31 was -$1.22M.
- COSCIENS Biopharma Inc. increase decrease in cash and cash equivalents for the quarter ending 2025-09-30 was -$809.00K.
- COSCIENS Biopharma Inc. increase decrease in cash and cash equivalents for the quarter ending 2025-06-30 was -$4.42M, a 118.21% decline year-over-year.
- COSCIENS Biopharma Inc. increase decrease in cash and cash equivalents for the quarter ending 2025-03-31 was -$2.63M.
| Period end | Increase Decrease In Cash And Cash Equivalents 3 month | Increase Decrease In Cash And Cash Equivalents 3 month as first filed | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 6 month as first filed | Increase Decrease In Cash And Cash Equivalents 9 month | Increase Decrease In Cash And Cash Equivalents 9 month as first filed | Increase Decrease In Cash And Cash Equivalents 12 month | Increase Decrease In Cash And Cash Equivalents 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$1.22M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | -$2.03M derived: sum of 2 quarters · filed 2026-03-25 | -$6.45M derived: sum of 3 quarters · filed 2026-03-25 | -$9.09M 20-F · filed 2026-03-25 | ||||
| 2025-09-30 | -$809.00K 6-K · filed 2025-11-12 | -$5.23M derived: sum of 2 quarters · filed 2025-11-12 | -$7.87M 6-K · filed 2025-11-12 | -$11.47M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2025-06-30 | -$4.42M 6-K · filed 2025-08-14 | -$7.06M 6-K · filed 2025-08-14 | -$10.66M derived: sum of 3 quarters · filed 2026-03-25 | -$18.47M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2025-03-31 | -$2.63M 6-K · filed 2025-05-13 | -$6.24M derived: sum of 2 quarters · filed 2026-03-25 | -$14.05M derived: sum of 3 quarters · filed 2026-03-25 | $10.25M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-12-31 | -$3.60M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | -$11.41M derived: sum of 2 quarters · filed 2026-03-25 | $12.89M derived: sum of 3 quarters · filed 2026-03-25 | $9.71M 20-F · filed 2026-03-25 | ||||
| 2024-09-30 | -$7.81M 6-K · filed 2025-11-12 | $16.49M derived: sum of 2 quarters · filed 2025-11-12 | $13.32M 6-K · filed 2025-11-12 | $11.63M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-06-30 | $24.30M 6-K · filed 2025-08-14 | $21.13M 6-K · filed 2025-08-14 | $19.44M derived: sum of 3 quarters · filed 2026-03-25 | $19.27M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-03-31 | -$3.17M 6-K · filed 2025-05-13 | -$4.47M 6-K · filed 2024-05-16 | -$4.86M derived: sum of 2 quarters · filed 2026-03-25 | -$5.03M derived: sum of 3 quarters · filed 2026-03-25 | -$5.79M derived: sum of 4 quarters · filed 2026-03-25 | |||
| 2023-12-31 | -$1.69M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | -$1.86M derived: sum of 2 quarters · filed 2026-03-25 | -$2.62M derived: sum of 3 quarters · filed 2026-03-25 | -$3.51M 20-F · filed 2026-03-25 | -$16.59M 20-F · filed 2024-03-27 | |||
| 2023-09-30 | -$174.00K 6-K · filed 2024-11-12 | -$3.43M 6-K · filed 2023-11-09 | -$931.00K derived: sum of 2 quarters · filed 2024-11-12 | -$1.83M 6-K · filed 2024-11-12 | -$11.86M 6-K · filed 2023-11-09 | $10.54M derived: sum of 4 quarters · filed 2025-04-09 | ||
| 2023-06-30 | -$757.00K 6-K · filed 2024-08-13 | -$4.37M 6-K · filed 2023-08-09 | -$1.65M 6-K · filed 2024-08-13 | -$8.43M 6-K · filed 2023-08-09 | $10.71M derived: sum of 3 quarters · filed 2025-04-09 | $6.37M derived: sum of 4 quarters · filed 2025-04-09 | ||
| 2023-03-31 | -$4.05M 6-K · filed 2024-05-16 | $11.47M derived: sum of 2 quarters · filed 2025-04-09 | $7.13M derived: sum of 3 quarters · filed 2025-04-09 | $1.69M derived: sum of 4 quarters · filed 2025-04-09 | ||||
| 2022-12-31 | $15.52M derived: 20-F 12 month − 6-K 9 month · filed 2025-04-09 | $11.18M derived: sum of 2 quarters · filed 2025-04-09 | $5.74M derived: sum of 3 quarters · filed 2025-04-09 | $4.03M 20-F · filed 2025-04-09 | -$14.69M 20-F · filed 2023-03-23 | |||
| 2022-09-30 | -$4.34M 6-K · filed 2023-11-09 | -$9.78M derived: sum of 2 quarters · filed 2023-11-09 | -$11.48M 6-K · filed 2023-11-09 | -$14.19M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2022-06-30 | -$5.44M 6-K · filed 2023-08-09 | -$7.14M 6-K · filed 2023-08-09 | -$9.85M derived: sum of 3 quarters · filed 2024-07-17 | -$11.71M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2022-03-31 | -$1.70M 6-K · filed 2023-05-09 | -$4.41M derived: sum of 2 quarters · filed 2024-07-17 | -$6.27M derived: sum of 3 quarters · filed 2024-07-17 | -$9.78M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2021-12-31 | -$2.70M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | -$4.57M derived: sum of 2 quarters · filed 2024-07-17 | -$8.07M derived: sum of 3 quarters · filed 2024-07-17 | $41.03M 20-F/A · filed 2024-07-17 | ||||
| 2021-09-30 | -$1.87M 6-K · filed 2022-11-03 | -$5.37M derived: sum of 2 quarters · filed 2022-11-03 | $43.73M 6-K · filed 2022-11-03 | $46.26M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-06-30 | -$3.50M 6-K/A · filed 2022-08-04 | $45.60M 6-K/A · filed 2022-08-04 | $48.12M derived: sum of 3 quarters · filed 2024-02-15 | $63.13M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-03-31 | $49.10M 6-K · filed 2022-05-11 | $51.63M derived: sum of 2 quarters · filed 2024-02-15 | $66.63M derived: sum of 3 quarters · filed 2024-02-15 | $64.19M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2020-12-31 | $2.52M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-15 | $17.53M derived: sum of 2 quarters · filed 2024-02-15 | $15.09M derived: sum of 3 quarters · filed 2024-02-15 | $16.43M 20-F/A · filed 2024-02-15 | ||||
| 2020-09-30 | $15.00M 6-K · filed 2021-11-04 | $12.56M derived: sum of 2 quarters · filed 2021-11-04 | $13.91M 6-K · filed 2021-11-04 | $10.88M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2020-06-30 | -$2.44M 6-K · filed 2021-08-05 | -$1.09M 6-K · filed 2021-08-05 | -$4.12M derived: sum of 3 quarters · filed 2022-03-29 | -$2.94M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2020-03-31 | $1.34M 6-K · filed 2021-05-05 | -$1.68M derived: sum of 2 quarters · filed 2022-03-29 | -$501.00K derived: sum of 3 quarters · filed 2022-03-29 | -$2.17M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2019-12-31 | -$3.02M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-29 | -$1.84M derived: sum of 2 quarters · filed 2022-03-29 | -$3.52M derived: sum of 3 quarters · filed 2022-03-29 | -$6.67M 20-F · filed 2022-03-29 | ||||
| 2019-09-30 | $1.18M 6-K · filed 2020-11-05 | -$495.00K derived: sum of 2 quarters · filed 2020-11-05 | -$3.65M 6-K · filed 2020-11-05 | -$5.94M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$1.67M 6-K · filed 2020-08-06 | -$4.83M 6-K · filed 2020-08-06 | -$7.12M derived: sum of 3 quarters · filed 2020-08-06 | -$10.26M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$3.15M 6-K/A · filed 2020-05-11 | -$5.44M derived: sum of 2 quarters · filed 2020-05-11 | -$8.59M derived: sum of 3 quarters · filed 2020-05-11 | -$13.19M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | -$2.29M derived: 20-F 12 month − 6-K 9 month · filed 2020-03-31 | -$5.43M derived: sum of 2 quarters · filed 2020-03-31 | -$10.04M derived: sum of 3 quarters · filed 2020-03-31 | $6.73M 20-F · filed 2020-03-31 | ||||
| 2018-09-30 | -$3.15M 6-K · filed 2019-11-07 | -$7.75M derived: sum of 2 quarters · filed 2019-11-07 | $9.02M 6-K · filed 2019-11-07 | |||||
| 2018-06-30 | -$4.60M 6-K · filed 2019-08-13 | $12.17M 6-K · filed 2019-08-13 | ||||||
| 2017-12-31 | -$14.22M 20-F · filed 2020-03-31 | |||||||
| 2016-12-31 | -$19.45M 20-F · filed 2019-04-01 | |||||||
| 2015-12-31 | $6.52M 20-F · filed 2018-03-28 |